Autonomix Medical, Inc. AMIX 深 沪
交易中 07-14 11:12:03 美东时间
4.99
-0.760
-13.22%
华盛通- 最 高5.38
- 今 开5.38
- 成交量 6.31万股
- 最 低 4.75
- 昨 收 5.75
- 总市值 271.11万
- 52周最高 32.55
- 市盈率 静 --
- 换手率 11.62%
- 52周最低 4.2042
- 委 比 -98.02%
- 总股本 54.33万
- 历史最高 451.29
- 量 比 0.50
- 振 幅 10.96%
- 历史最低 4.2042
- 每 手 1
- 风险率 7.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Autonomix Medical Announces 1-For-21 Reverse Stock Split, Effective June 24
Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of D...
06-19 04:31
Autonomix Medical Presents Clinical Significance Data At Society Of Surgical Oncology Annual Meeting
Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it recently participated in a Virtual
06-04 21:13
Why 8x8 Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Shares of 8x8 Inc (NASDAQ: EGHT) jumped 13.3% in pre-market trading after reporting better-than-expected Q4 results, with adjusted earnings of 11 cents per share and revenue of $185.25 million. GCL, PETZ, WOK, MEHA, HAO, TDIC, FEED, KELYA, and AMC were among the top gainers, while RUBI, AMIX, IPW, ANVS, and WGRX were among the top losers in pre-market trading.
05-20 16:31
Autonomix Medical Announces USPTO Issues U.S. Patent Titled Systems, Methods, And Devices For Monitoring And Treatment Of Tissues Within And/Or Through A Lumen Wall
Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wallPatent strengthens intellectual property foundation for next-generation neuromodulation
05-19 20:36
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Fr...
03-21 05:05
Autonomix Medical Presents New Subgroup Clinical Data From PoC Study At 2026 ASCO GI Demonstrating Durable And Meaningful Pain Relief In Pancreatic Cancer Patients Across All Disease Stages
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with otherwise limited treatment optionsTHE WOODLANDS, TX, Jan.
01-09 21:47
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of OceanFirst Financial Corp. (NASDAQ:OCFC) fell sharply during Tuesday'...
2025-12-31 01:31
Autonomix CEO Highlights IP Protection And Expansion Beyond Pancreatic Cancer Into Cardiovascular, Pulmonary, And Pain Management At Virtual Investor Connect
Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it recently participated in a Virtual Investor
2025-12-23 21:48
Autonomix Medical announces pricing of $5M private placement
Autonomix Medical (NASDAQ:AMIX) stated on Tuesday that it has entered into an agreement with a single institutional investor to purchase 4.5M shares of common stock and, together with unregistered Ser...
2025-11-18 21:59
Autonomix Medical shares are trading higher after the company reported post-hoc subgroup analysis results from its first-in-human study showing potential quality-of-life improvements with its targeted ablation therapy.
Autonomix Medical shares are trading higher after the company reported post-hoc...
2025-11-17 21:02
